Akso Health Group
AHG
NASDAQ·Healthcare·Medical - Distribution·Mkt cap $724.2M
$0.85
▼ -2.95%
P/E
-1.95
Mkt Cap
$724.2M
52-Wk Range
$0.84–$2.50
52-Week Range
$0.84 - $2.50
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 52.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Established social e-commerce platform with integrated user community
- Diverse product portfolio reducing dependency on single categories
- Strong positioning in China's high-growth mobile commerce market
- Technology and consultancy services creating customer stickiness
Bear Case
1 risk
- Low volatility (beta -1.1).
Growth
Turning profitable
Expansion of social commerce adoption in lower-tier Chinese cities
Value
Valuation data unavailable
Momentum
Falling
-36.2% over 3m
Quality
Loss-making
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying AHG right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 13, 2026
Most recent quarter reported revenue of $3.4M (-13% YoY). Reported EPS of -$0.03. Gross margin -0.3%.
Reported EPS · last 4Q
Q4 26
-$0.03
Q4 25
-$0.20
Q3 24
-$0.20
Q2 24
-$0.00
Revenue trend · last 8Q
—
—
—
+676%
+676%
+416%
+416%
-13%
Q2 23
Q3 23
Q4 24
Q1 24
Q2 24
Q3 24
Q4 25
Q4 26
$446.8K
$760.4K
$760.4K
$3.5M
$3.5M
$3.9M
$3.9M
$3.4M
Margins · last 8Q
Gross
-0.3%
Operating
—
Profit
-546.5%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How AHG stacks vs Medical - Distribution
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related